Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03399630
Other study ID # ATOA-01
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 9, 2016
Est. completion date May 31, 2018

Study information

Verified date June 2018
Source Aestique Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Evaluating the safety and efficacy of a single injection of autologous adipose tissue for treatment of osteoarthritis of the knee.


Description:

This clinical trial is a single site, double blinded, paired within groups, controlled clinical study to investigate the safety and efficacy in the use of adult autologous adipose tissue for the treatment of pain associated with joint OA. The hypothesis of this trial is that the treatment will be safe and the proposed clinical outcome measures of reduced pain resulting from the treatment of OA of the knee joint with autologous adipose tissue will be superior to a placebo control treatment.


Recruitment information / eligibility

Status Completed
Enrollment 8
Est. completion date May 31, 2018
Est. primary completion date February 28, 2018
Accepts healthy volunteers No
Gender All
Age group 40 Years to 75 Years
Eligibility Inclusion Criteria:

1. Bilateral K-L Grade II through Grade IV osteoarthritis as diagnosed by physician review of weight bearing X-ray or MRI excluding subjects whose knee pain is caused by, (i) diffuse edema, (ii) displaced meniscus tear, (iii) lesion greater than 1 cm in any direction, or (iv) osteochondritis dissecans.

2. Study Participants must be willing to voluntarily give written Informed Consent to participate in the study and sign the Health Insurance Portability and Accountability Act (HIPAA) authorization before any study procedures are performed.

3. Males and females 40-75 years old.

4. Participants will be in good health (ASA Class I-II) with a BMI < 35.

5. Continued pain in the knee despite conservative therapies for at least 6 months.

6. Participants must present with a bilateral knee pain scores =6 and =16 using the short-form WOMAC pain (A1 subscale, 20 total points).

7. Must speak, read and understand English.

8. Subjects must be reasonably able to return for multiple follow-up visits.

Exclusion Criteria:

1. Participants who have had surgery of either knee within 6 months prior to the screening visit.

2. Participants who have had a major injury to either knee within 12 months prior to enrolling in the study.

3. Participants who have had an injection in either knee in the prior 6 months, including corticosteroids, viscosupplementation or platelet rich plasma (PRP).

4. Participants who have gout, rheumatoid arthritis, lupus arthropathy, psoriatic arthritis, avascular necrosis, severe bone deformity, infection of the knee joint, fibromyalgia, pes anserine bursitis, or neurogenic or vascular claudication.

5. Participants who have symptomatic OA of the hips, spine, or ankle that would interfere with the evaluation of the treated knee.

6. Participants that are unwilling to stop taking prescription pain medication 7 days prior to any visit.

7. Participants that are allergic to lidocaine, epinephrine or valium

8. History of bleeding disorders, anticoagulation therapy that cannot be stopped 3 days prior to injection

9. Subjects that use any form of tobacco to include e-cigarettes more than once a week within the last 6 months

Study Design


Intervention

Other:
Injection of Autologous Adipose Tissue
Injection of Autologous Adipose Tissue to study the safety and efficacy of treating osteoarthritis
Injection of lactated ringers
Injection of placebo lactated ringers to compare against the injection of autologous adipose tissue.

Locations

Country Name City State
United States Aestique Ambulatory Surgical Center Greensburg Pennsylvania
United States DNA Advanced Pain Treatment Greensburg Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
Aestique Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Efficacy - Change in Pain Scores on the VAS Scale at All Follow-Up Visits Patient outcomes for pain will be recorded 1 week, 6 weeks, 3 months, and 6 months
Other Efficacy - Change in Function Scores on the VAS Scale at All Follow-Up Visits Patient outcomes for function will be recorded 1 week, 6 weeks, 3 months, and 6 months
Other Efficacy - Change in Stiffness Scores on the VAS Scale at All Follow-Up Visits Patient outcomes for stiffness will be recorded 1 week, 6 weeks, 3 months, and 6 months
Primary Safety - Incidence of Treatment-Emergent Adverse Events Subjects will be monitored for adverse events 6 months
Secondary Efficacy - Change in Pain Scores on the WOMAC Scale at All Follow-Up Visits Patient outcomes for pain will be recorded 1 week, 6 weeks, 3 months, and 6 months
Secondary Efficacy - Change in Function Scores on the WOMAC Scale at All Follow-Up Visits Patient outcomes for function will be recorded 1 week, 6 weeks, 3 months, and 6 months
Secondary Efficacy - Change in Stiffness Scores on the WOMAC Scale at All Follow-Up Visits Patient outcomes for stiffness will be recorded 1 week, 6 weeks, 3 months, and 6 months
See also
  Status Clinical Trial Phase
Terminated NCT04040985 - Legion Primary Safety and Efficacy N/A
Active, not recruiting NCT04525950 - Robotized Navigation Compared to Conventional Technique in Total Knee Replacement N/A
Recruiting NCT04320914 - High Intensity Laser Therapy (Classes IV) and Ibuprofen Gel Phonophoresis for Treating Knee Osteoarthritis N/A
Completed NCT03886142 - Platelet Rich Plasma Versus Radio Frequency for Chronic Knee Arthritis N/A
Terminated NCT04072055 - MOTO Post-marketing Surveillance Study
Not yet recruiting NCT06385275 - The Role of Vitamin K on Knee Osteoarthritis Outcomes Phase 1/Phase 2
Not yet recruiting NCT05290818 - Total Versus Robotic Assisted Unicompartmental Knee Replacement N/A
Withdrawn NCT03271229 - Conventional Platelet-Rich Plasma Versus Concentrated Bone Marrow Stem Cell Injections for Osteoarthritis of the Knee Phase 2
Recruiting NCT05992038 - Use of a Putty as Gap Filler in Open-wedge Osteotomy N/A
Recruiting NCT05505552 - Effects of Vitamin K on Lower-extremity Function in Adults With Osteoarthritis: N/A
Recruiting NCT06066684 - Pain Phenotyping in Knee OA: a Pilot Trial
Completed NCT03847324 - Physiotherapy and Therapeutic Education on Patients With Pain Catastrophism Scheduled for a Total Knee Arthroplasty N/A
Recruiting NCT05126485 - Biofeedback Retention in Individuals With AKA Early Phase 1
Completed NCT04956393 - The SOAR (Stop OsteoARthritis) Program Proof-of-Concept Study N/A
Recruiting NCT04541342 - Arthroscopic Evaluation of Cartilage Regeneration After Opening-wedge High Tibial Osteotomy N/A
Completed NCT04391842 - Sustained Acoustic Medicine (SAM) Combined With a Diclofenac Ultrasound Coupling Patch for Knee Osteoarthritis Phase 1
Completed NCT03680807 - Power Production in Older Adults With Knee Osteoarthritis
Completed NCT03783455 - Effectiveness of Five Intraarticular Strategies on Knee Osteoarthritis N/A
Not yet recruiting NCT06264362 - Developing a Nonpharmacological Pain Intervention for Community-dwelling Older Adults With Dementia N/A
Completed NCT05089253 - Effect of Physical Therapy Modalities in Osteoarthritis N/A